Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.89
-0.41 (-6.51%)
May 12, 2026, 11:20 AM EDT - Market open
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $611.89 million as of May 12, 2026. Its market cap has increased by 11.65% in one year.
Market Cap
611.89M
Enterprise Value
726.90M
1-Year Change
11.65%
Ranking
Category
Stock Price
$5.89
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $611.89M, an increase of 35.69%. That is a compound annual growth rate of 2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 611.89M | -18.86% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 647.83M |
| Zevra Therapeutics | 638.44M |
| BridgeBio Oncology Therapeutics | 631.46M |
| Kyverna Therapeutics | 625.88M |
| Arvinas | 623.24M |
| Cabaletta Bio | 622.85M |
| Crescent Biopharma | 615.40M |
| CorMedix | 600.87M |